Background and objective the study analysed the effectiveness and safety of warfarin use
compared with warfarin non-use and non-vitamin K antagonist oral anticoagulants (NOACs) …

Background Comparative data of non‐vitamin K antagonist oral anticoagulants (NOAC) are
lacking in patients with atrial fibrillation (AF). Objective We compared effectiveness and …

Background The Hypertension, Abnormal renal/liver function, Stroke, Bleeding, Labile
International Normalized Ratio (INR), Elderly, Drugs or alcohol use (HAS‐BLED) score has …

The objective of the study was to examine how the comparative effectiveness and safety of
direct oral anticoagulants (DOACs) and warfarin differ across subgroups of patients with …

Обзорная статья посвящена безопасности и эффективности применения прямых
оральных антикоагулянтов: ингибитора тромбина дабигатрана этексилата и …

When there is a need to compare three or more treatments for the same clinical indication,
the network meta-analysis (NeMa) offers the important advantage of “incorporating” in a …

The review article study the safety and efficacy of using direct acting oral anticoagulants:
thrombin inhibitor dabigatran etexilate and inhibitors Xa of the blood clotting factor apixaban …

Background Thromboembolic and bleeding risk are elevated in older patients with atrial
fibrillation and prior stroke. We compared dabigatran with rivaroxaban for secondary …

Частая коморбидность фибрилляции предсердий (ФП) и хронической болезни почек
(ХБП) в общей популяции продемонстрирована во многих эпидемиологических …

В статье рассматривается возможность назначения антикоагулянтной терапии
пожилым пациентам с фибрилляцией предсердий в различных клинических ситуациях …